NCT06413264

Brief Summary

Bariatric Surgery for morbid obesity is indicated when BMI \> 40 kg/m2 without comorbidities or BMI \> 35 kg/m2 with co-morbidities. Different surgeries performed for obesity are classified as restrictive, malabsorptive, and hybrid procedures. Because laparoscopic surgery has increased the interest and growth of bariatric surgery, soaring demand for laparoscopic bariatric surgery from patients has boosted the boom in bariatric surgery worldwide. Achieving pneumoperitoneum is the initial and one of the most crucial steps in any laparoscopic surgery, giving the surgeon working space to operate on a particular organ/organ system. Usually, pneumoperitoneum is achieved either by a closed technique with a veress needle or an open technique with many variations like finger assisted or the conventional open technique. Given the excess amount of subcutaneous fat in morbidly obese patients, putting a veress needle to achieve pneumoperitoneum successfully is particularly challenging which takes a toll on the operating surgeon when he/she is trying to locate the midline one can either overshoot to cause omental emphysema or undershoot getting lost in the subcutaneous fat. It is usually done in the supra umbilical area. Sometimes, due to previous surgical scars other sites are preferred. Sonography is routinely used by radiologists with negligible radiation exposure. Anesthesiologists in the operating room have used it for many assisted procedures like central line insertion / giving nerve blocks. It can also be used in obese patients undergoing metabolic surgery to assist in creating pneumoperitoneum by a veress needle. Advantages of Intraoperative ultrasonography in this particular study :

  1. 1.To quantify the thickness of subcutaneous fat
  2. 2.To visualise the linea alba and guide the veress needle safely into the peritoneal cavity
  3. 3.Real-time visualisation of the pneumoperitoneum created
  4. 4.Avoid complications like omental emphysema, bowel or vascular injury

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jul 2024Jun 2026

First Submitted

Initial submission to the registry

April 28, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 14, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

1.9 years

First QC Date

April 28, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

pneumoperitoneumclosed techniqueVeress needleultrasonography-guidedmorbidly obesebariatric surgerymetabolic surgeryaccess-related injury

Outcome Measures

Primary Outcomes (1)

  • Time taken to successfully insert the Veress needle (supra umbilical) into the peritoneal cavity in both arms.

    The time in seconds between the first attempt to insert the Veress needle into the peritoneal cavity and the onset of successful pneumoperitoneum (confirmed by either ultrasonography/saline drop/percussion) in morbidly obese patients undergoing laparoscopic bariatric procedures. A comparison of the time taken to successfully place the Veress needle in the peritoneal cavity by ultrasonography-guided insertion and by blind technique will be made.

    Time taken till the Veress needle tip enters the peritoneal cavity (Maximum allowed time up to 2 minutes). Beyond the time, the Veress needle to be attempted insertion at other sites, including the Palmer's point.

Secondary Outcomes (2)

  • Number of attempts to successful Veress needle insertion

    Veress needle tip enters the peritoneal cavity (Upto maximum 3 attempts within 2 minutes). Beyond the number of attempts or time, the Veress needle to be attempted insertion at other sites, including the Palmer's point.

  • Incidences of complications out of Veress needle insertion for creating pneumoperitoneum

    At the beginning of the laparoscopic surgical procedure, during the diagnostic laparoscopy, the complications (omental emphysema, bowel /vascular injury), if any inadvertently done will be recorded

Study Arms (2)

USG-guided Veress needle insertion

EXPERIMENTAL

Ultrasonography-guided Veress needle will be inserted, and a real-time pneumoperitoneum will be created as the first step of a laparoscopic bariatric surgical procedure. The bariatric procedures include laparoscopic sleeve gastrectomy and gastric bypass procedures. The ultrasound's high-frequency (10-13Hz) linear probe will be used peri-operatively to identify the planes of the abdominal wall. Once the Veress needle is successfully inserted into the peritoneal cavity in real-time visualisation and pneumoperitoneum created, thereafter the bariatric procedures will be continued as routinely done.

Procedure: Ultrasonography guided Veress needle insertion for creating pneumoperitoneum

Blind Veress needle insertion

ACTIVE COMPARATOR

The Veress needle is inserted blindly, as regularly done in any other laparoscopic surgery, and the successful pneumoperitoneum is confirmed by aspiration of the needle, saline drop test and percussion on the abdomen.

Procedure: Veress needle will be inserted blindly as a closed technique for creating pneumoperitoneum

Interventions

A real-time visualisation of the path of the Veress needle entry by the use of high frequency (13-6 MHz) probe ultrasonography.

Also known as: Sonosite Edge II Portable Ultrasound machine
USG-guided Veress needle insertion

The Veress needle is inserted blindly and guided by the resistance of tissues and the click sounds of layers of abdominal wall.

Also known as: Stainless steel spring loaded reusable hollow needle of 2mm in diameter and 15-18cm long
Blind Veress needle insertion

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients in the age group of 18 -65 years undergoing laparoscopic bariatric surgery with weight \>100 kg
  • Subcutaneous fat thickness of more than 5 cm as determined by pre-operative ultrasonography
  • BMI \> 40 kg/m2

You may not qualify if:

  • Patients who don't give consent and do not understand the nature of the study
  • Patients undergoing a re-do surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All India Institute of Medical Sciences

Bhubaneswar, Odisha, 751019, India

RECRUITING

MeSH Terms

Conditions

PneumoperitoneumObesity, Morbid

Condition Hierarchy (Ancestors)

Peritoneal DiseasesDigestive System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Prof. Prakash K. Sasmal, MS, FACS

    Professor of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, India

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr Prakash K. Sasmal, MS, FACS

CONTACT

Dr Pradeep K. Singh, MS, FACS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Only patients will be blinded about the allocations.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Single blinded randomised controlled study where only the patient is blinded
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of General Surgery

Study Record Dates

First Submitted

April 28, 2024

First Posted

May 14, 2024

Study Start

July 1, 2024

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

The study outcome will be shared after the end of the trial. An interim study outcome will be shared after half of the study subjects are recruited.

Locations